GLA from EPO is converted to DGLA (dihomo-gamma-linolenic acid) which produces PGE1 — a prostaglandin with anti-inflammatory, vasodilatory, and immune-modulating properties. This is unusual because most omega-6 fatty acids are converted to arachidonic acid and pro-inflammatory prostaglandins. The delta-5-desaturase enzyme normally converts DGLA → arachidonic acid, but GLA supplementation overwhelms this step, favoring the anti-inflammatory PGE1 pathway. In diabetic neuropathy, GLA restores nerve blood flow and nerve membrane fatty acid composition.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.